Royal Bank Of Canada Biomerica Inc Transaction History

Royal Bank Of Canada

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.71 - $1.65 $100 - $234	-142 Reduced 71.36%	57 $0
Q3 2023 Nov 14, 2023	SELL	$0.82 - $1.65 $186 - $376	-228 Reduced 53.4%	199 $0
Q2 2023 Aug 14, 2023	BUY	$1.12 - $1.87 $478 - $798	427 New	427 $0
Q3 2022 Nov 14, 2022	BUY	$2.61 - $3.98 $20 - $31	8 New	8 $0

1.79M

53.7K

Ticker BMRA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 13,427,700
Market Cap $4.3M
Description
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various disea...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.